Morgan Stanley Genfit S.A. Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Genfit S.A. stock. As of the latest transaction made, Morgan Stanley holds 32,764 shares of GNFT stock, worth $192,652. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,764
Previous 28,464
15.11%
Holding current value
$192,652
Previous $101,000
16.83%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding GNFT
# of Institutions
8Shares Held
49.2KCall Options Held
0Put Options Held
0-
Old Mission Capital LLC12.8KShares$75,3630.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P72.24KShares$13,1880.0% of portfolio
-
Rhumbline Advisers Boston, MA678Shares$3,9860.0% of portfolio
-
Ubs Group Ag346Shares$2,0340.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ273Shares$1,6050.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $293M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...